Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway

Infection and Immunity

Volumn 64, Issue 5, 1996, Pages 1846-1849

  Roy, Didier Le ^a   Morand, Philippe ^a   Lengacher, Sylvain ^a   Celio, Marco ^b   Grau, Georges E ^c   Glauser, Michel Pierre ^a   Heumann, Didier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Institute of Histology   (Switzerland)

^c HCU Geneva ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOMODULATION; LETHALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS MITIS;

EID: 9244260502     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.5.1846-1849.1996     Document Type: Article

References (34)

1. Awada, A., P. van der Auwera, F. Meunier, D. Daneau, and J. Klastersky. 1992. Streptococcal and enterococcal bactercmia in patients with cancer Clin. Infect. Dis. 15:33-48.
2. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:4614-4620.
3. Bochud, P. Y., P. Eggiman, T. Calandra, G. van Melle, L. Saghafi, and P. Francioli. 1994. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin. Infect. Dis. 18:25-31.
4. Bone, R. C. 1994. Gram-positive organisms and sepsis. Arch. Intern Med. 154:26-34.
5. Bonventre, P. F., H. Heeg, C. Cullen. and C.-J. Lian. 1993 Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 61:793-799.
6. Cavaillon, J. M., and N. Haeffner-Cavaillon. 1986. Polymyxin-B inhibition of LPS-induced imerleukin-1 secretion by human monocytes is dependent upon the LPS origin. Mol. Immunol. 23:965-969.
7. Cohen, J., A. M. Worsley, J. M. Goldman, J. P. Donnelly, D. Catovsky, and D. A. G. Gallon. 1983. Septicemia caused by viridans streptococci in neutropenic patients with leukemia Lancet. ii:1452-1454.
8. Elting, L. S., G. P. Bodey, and B. H. Keefe. 1992. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin. Infect. Dis. 14:1201-1207.
9. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110-2115.
10. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Cialactosamineinduced sensitisation to the lethal effect of endotoxin. Proc. Natl. Acad Sci. USA 76:5939-5943
11. Heumann, D., C. Barras, A. Severin, M. P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:2715-2721.
12. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992 Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids Infect. Immun 60:3664-3672.
13. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice J. Exp. Med. 165:657-663.
14. Matsushita, K., W. Fujimaki, H. Kato, T. Uchiyama, H. Igarashi, H. Ohkuni, S. Nagaoka, M. Kawagoe, S. Kotani, and H. Takada. 1995. Immunopathological activities of extracellular products of Streptococcus nulls, particularly a superantigenic fraction. Infect. Imrnun. 63:785-793.
15. Mattsson, E., J. Rollof, J. Verhoef, H. van Dijk, and A. Fleer. 1994. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect. Immun. 62:3837-3843.
16. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992 T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 175:91-98.
17. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818
18. Natanson, C., R. L. Danner, R. J. Elin, J. M. Hosseini, K. W. Peart, S. M. Banks, T. J. MacVittie, R. I. Walker, and J. E. Parrillo. 1989. Role of endotoxemia in cardiovascular dysfunction and mortality. Eschtrichia coli and Staphylococcus aureus challenges in a canine model of human septic shock J. Clin. Invest. 83:243-251.
19. Parsonnet, J. 1989 Mediators in the pathogenesis of toxic shock syndrome: overview Rev. Infect. Dis. 11(Suppl. 1):263-269.
20. Pratter, M. R., and R. S. Irwin. 1980. Viridans streptococcal pulmonary parenchymal infections. JAMA 243:2515-2517.
21. Pugin, J., D. Heumann, A. Tomasz, V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516
22. Remick, D. G., R. M. Strieter, M. K. Eskandari, D. T. Ngoyen, M. A. Genord, C. L. Raiford, and S. L. Kunkel. 1990. Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am. J Pathol 136:49-60.
23. Roberson, B. S., and J. H. Schwab. 1961. Endotoxin properties associated with cell walls of group A streptococci. J Infect. Dis. 108:25-34.
24. Stokes, D. C., J. L. Shenep, M. Fishman, W. K. Hildner, G. K. Bysani, and K. Rufus. 1989. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-α from alveolar macrophages. J. Infect Dis. 160:52-57.
25. Suzuki, K., H. Ota, S. Sasagawa, T. Sakatani, and T. Fujikura. 1983 Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132:345-352.
26. Takada, H., Y. Kawabata, M. Tamura, K. Matsushita, H. Igarashi, H. Ohkuni, Y. Todome, T. Uchiyama, and S. Kotani. 1993 Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun. 61:5252-5260.
27. Ulevitch, R. J., and P. S. Tobias. 1994. Recognition of endotoxin by cells leading to transmembrane signaling. Curr. Biol. 6:125-130.
28. Wakabayashi, G., J. A. Gelfand, W. K. Jung, R. J. Connolly, J. F. Burke, and C. A. Dinarello. 1991. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1. a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli J. Clin. Invest. 87:1925-1935.
29. Wardle, N. 1979. Bacteraemic and endotoxin shock Br. J Hosp. Med., p. 223-231.
30. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bažil, S. Kusumoto, H.-D. Flad, and A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can he blocked by anti-CD 14 monoclonal antibodies and by lipid A partial structures Infect. Immun. 62:4709-4715.
31. Weiland, J. E., W. B. Davis, J. F. Holter, J. R. Mohammed, P. M. Dorinsky, and J. E. Gadek. 1986. Lung neutropluls in the adult respiratory distress syndrome. Clinical and pathophysiologic significance Am Rev. Respir Dis. 133:218-225
32. Welbourn, C. R. B., and Y. Young. 1992. Endotoxin. septic shock, and acute lung injury neutrophils, macrophages and inflammatory mediators Br. J. Surg. 79:998-1003.
33. Wiles, J. B., F. B. Cerra, J. H. Siegel, and J. R. Border. 1980. The systemic septic response: does the organism matter? Crit. Care. Med. 8:55-60.
34. Zanetti, G., D. Heumnann, J. Gerain, J. Kohler, P. Abbet, C. Barras, M. P. Glauser, and J. D. Baumgartner. 1992 Cytokine production after intravenous or peritoneal Gram negative bacterial challenge in mice. Comparative protective efficacy of antibodies to TNFα and to LPS. J. Immunol. 148:1890-1897.